Dublin, Ireland – March 15th, 2018 – Aalto Bio Reagents yesterday signed its first distribution agreement with a Chinese partner, Seebio Biotech Co. Ltd., while on a Team Ireland led trade mission. This major trade mission attended by An Tánaiste, Simon Coveney, aims to build strategic relationships with potential business partners like Seebio Biotech. Irish trade with China has doubled in the last 4 years and with the Chinese in-vitro diagnostic market expected to triple by 2022, this presents an excellent opportunity for companies such as Aalto Bio Reagents to further expand its customer reach and to capitalize on this growth.
Aalto Bio’s CEO, Philip Noone, signing the partner agreement with Seebio’s CEO, Fyland Zhang, in the presence of An Tánaiste, Simon Coveney, and Ireland’s Ambassador to China, Eoin O’Leary.
Aalto Bio already has a strong presence in the IVD market in Europe, and has recently expanded into Brazil, Japan, Korea and the U.S. with the growing demand for its tropical virus antigens and antibodies. Philip Noone, CEO of Aalto Bio Reagents, said “the signing of this first ever distribution agreement with a Chinese partner opens up a whole new territory for us and will help broaden our global presence. Our industry has an unrelenting requirement for access to the most scientifically proven raw materials, a broader range of flexible controls and faster diagnostics, and China is no exception. With Seebio’s extensive experience in the field of life science, we are confident that they are the perfect partner to grow and develop our business in China.”
About Seebio Biotech
Founded in 2003, Seebio Biotech is both a manufacturer and supplier of analytical reagents, biochemical reagents, catalysts, lab wares and consumables. It has been publically quoted on the over-the-counter (OTC) stock exchange in China since July 2016 and has distribution channels in all the major cities in China including Shanghai, Beijing and Xiamen. The company is rapidly expanding and expects to double its building size and staff number in the next 2 years.
About Aalto Bio Reagents
Founded in 1978, Aalto Bio Reagents is a leading developer and provider of raw materials to the in-vitro diagnostics industry and to research laboratories globally. It serves the largest multinational companies in its industry with a broad range of purified human proteins; monoclonal and polyclonal antibodies; fungal, parasitic, bacterial and viral antigens; and disease state plasma for in-vitro diagnostic application.
Since the company's inception, it has built strong working relationships with its clients who trust us to provide them with the highest quality raw materials to meet the exacting standards of their own product development requirements. Headquartered in Dublin, Ireland, the company is rapidly expanding both its product portfolio and customer base.
For further information please visit www.aaltobioreagents.com
Technical Sales Tel: +353-1-4900685